Boardroom Alpha
Boardroom Alpha
UHS · Current Report (Form 8-K) · Filed May 22, 2026

Universal Health Services Inc — Current Report (Form 8-K)

Form
8-K
Filed
May 22, 2026
Period
May 20, 2026
Ticker
UHS
Accession
0001193125-26-235480
Boardroom Alpha · Filing insights

Two Class III directors elected; say-on-pay approved; PwC ratified; 'votes at risk' proposal failed; NYS withdrew diversity proposal.

About Universal Health Services Inc
Market cap
$8.6B
1Y TSR
−9.1%
3Y TSR
+4.4%
Board grade
B-
Sector
Healthcare
CEO
Marc D Miller
Last annual meeting: May 20, 2026 · View full Universal Health Services Inc profile →
8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 20, 2026

UNIVERSAL HEALTH SERVICES, INC.

(Exact name of registrant as specified in its charter)

Delaware

1-10765

23-2077891

(State or other jurisdiction of

(Commission

(I.R.S. Employer

Incorporation or Organization)

File Number)

Identification No.)

UNIVERSAL CORPORATE CENTER

367 SOUTH GULPH ROAD

KING OF PRUSSIA, Pennsylvania 19406

(Address of principal executive office) (Zip Code)

Registrant’s telephone number, including area code (610) 768-3300

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Class B Common Stock

UHS

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.


Item 5.07 Submission of Matters to a Vote of Security Holders.

On May 20, 2026, the Company held its 2026 Annual Meeting of Stockholders. This year’s Annual Meeting of Stockholders was conducted virtually via a live audio webcast.

At the Annual Meeting, the Company’s stockholders: (i) voted to elect two Class III members of the Board of Directors for a three-year term scheduled to expire at the Company’s 2029 Annual Meeting of Stockholders; (ii) voted to approve, on an advisory (non-binding) basis, the compensation paid to the Company's named executive officers; (iii) voted to ratify the selection of PricewaterhouseCoopers, LLP, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, and; (iv) voted against the stockholder proposal regarding reporting votes based on UHS shareholder money at risk. The final voting results were as follows:

Proposal No. 1: Election of Directors:

Alan B. Miller – elected by the Class A and Class C Stockholders:

 

 

Votes cast in favor

7,236,288

Votes withheld

0

Non-votes

0

Nina Chen-Langenmayr – elected by the Class B and Class D Stockholders:

 

 

Votes cast in favor

31,836,231

Votes withheld

14,129,963

Non-votes

2,535,388

Proposal No. 2: Advisory vote on named executive compensation:

 

 

Votes cast in favor

62,219,230

Votes cast against

228,600

Votes abstained

1,996

Non-votes

262,607

Proposal No. 3: Ratification of the selection of PricewaterhouseCoopers, LLP, as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026:

 

 

Votes cast in favor

62,633,332

Votes cast against

77,514

Votes abstained

1,586

Non-votes

0

Proposal No. 4: Stockholder proposal to report votes based on UHS shareholder money at risk:

 

 

Votes cast in favor

2,917,981

Votes cast against

59,513,156

Votes abstained

18,688

Non-votes

262,607

After the proxy statement was issued, the New York State Common Retirement Fund withdrew its proposal to adopt a policy requiring the Registrant to publicly disclose its workforce diversity. Therefore, there was no vote for Proposal No. 5 held or announced at the meeting.

 


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Universal Health Services, Inc.

 

By:

/s/ Steve Filton

Name: Steve Filton

Title: Executive Vice President and

            Chief Financial Officer

Date: May 22, 2026

 

 

 


From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Universal Health Services Inc (UHS)

Reference

Frequently asked questions

When did Universal Health Services Inc file this 8-K?
Universal Health Services Inc (UHS) filed this Current Report (Form 8-K) with the SEC on May 22, 2026. The accession number assigned by EDGAR is 0001193125-26-235480.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Two Class III directors elected; say-on-pay approved; PwC ratified; 'votes at risk' proposal failed; NYS withdrew diversity proposal. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Universal Health Services Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Universal Health Services Inc has filed under CIK 352915, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer